References
- UCB [Internet]Cimzia (certolizumab pegol) offers 2 formulation options to align with patient needs2016 Available from: http://cimziahcp.com/formulation-optionsAccessed April 19, 2017
- SandbornWJFeaganBGStoinovSCertolizumab pegol for the treatment of Crohn’s diseaseN Engl J Med2007357322823817634458
- SchreiberSKhaliq-KareemiMLawranceICfor the PRECISE 2 Study InvestigatorsMaintenance therapy with certolizumab pegol for Crohn’s diseaseN Engl J Med2007357323925017634459
- SandbornWJLeeSDRandallCLong-term safety and efficacy of certolizumab pegol in the treatment of Crohn’s disease: 7-year results from the PRECiSE 3 studyAliment Pharmacol Ther201440890391625146586
- World Health Organization [Internet]Adherence to long-term therapies: evidence for actionGeneva, Switzerland2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed April 19, 2017
- HanauerSBWagnerCLBalaMIncidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s diseaseClin Gastroenterol Hepatol20042754255315224278
- GanguliAClewellJShillingtonACThe impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic reviewPatient Prefer Adherence20161071172527175071
- Cimzia (certolizumab pegol) [prescribing information]Smyrna, GAUCB Inc2008
- MalehiASPourmotahariFAngaliKAStatistical models for the analysis of skewed healthcare cost data: a simulation studyHealth Econ Rev [serial on Internet]201551116 Available from: https://healtheconomicsreview.springeropen.com/articles/10.1186/s13561-015-0045-7
- BarberJThompsonSMultiple regression of cost data: use of generalised linear modelsJ Health Serv Res Policy20049419720415509405
- ManningWGMullahyJEstimating log models: to transform or not to transform?J Health Econ200120446149411469231
- LevyRLFeldADIncreasing patient adherence to gastroenterology treatment and prevention regimensAm J Gastroenterol19999471733174210406229
- KaneSVChaoJMulaniPMAdherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patientsAdv Ther2009261093694619838649
- BillioudVLaharieDFilippiJAdherence to adalimumab therapy in Crohn’s disease: a French multicenter experienceInflamm Bowel Dis201117115215921061388
- Degli EspostiLSangiorgiDPerroneVAdherence and resource use among patients treated with biologic drugs: findings from BEETLE studyClinicoecon Outcomes Res2014640140725258545
- IugaAOMcGuireMJAdherence and health care costsRisk Manag Healthc Policy20147354424591853
- MehtaFReport: economic implications of inflammatory bowel disease and its managementAm J Manag Care2016223 SupplS51S6027269903
- FarmerRGWhelanGFazioVWLong-term follow-up of patients with Crohn’s disease. Relationship between the clinical pattern and prognosisGastroenterology1985886181818253922845
- LichtensteinGRYanSBalaMHanauerSRemission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeriesAm J Gastroenterol2004991919614687148
- ParkKTCollettiRBRubinDTSharmaBKThompsonAKruegerAHealth insurance paid costs and drivers of costs for patients with Crohn’s disease in the United StatesAm J Gastroenterol20161111152326195179
- GraffLAWalkerJRBernsteinCNDepression and anxiety in inflammatory bowel disease: a review of comorbidity and managementInflamm Bowel Dis20091571105111819161177
- LoftusEVJrGuérinAYuAPIncreased risks of developing anxiety and depression in young patients with Crohn’s diseaseAm J Gastroenterol201110691670167721537359
- NahonSLahmekPDuranceCRisk factors of anxiety and depression in inflammatory bowel diseaseInflamm Bowel Dis201218112086209122294486
- AnanthakrishnanANGainerVSPerezRGPsychiatric comorbidity is associated with increased risk of surgery in Crohn’s diseaseAliment Pharmacol Ther201337444545423289600
- AnanthakrishnanANGainerVSCaiTSimilar risk of depression and anxiety following surgery or hospitalization for Crohn’s disease and ulcerative colitisAm J Gastroenterol2013108459460123337479
- CharlsonMSzatrowskiTPPetersonJGoldJValidation of a combined comorbidity indexJ Clin Epidemiol19944711124512517722560